Back to search
Maternal Exposure
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Maternal Exposure trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Maternal Exposure trials you may qualify forIn-utero exposure to drugs and chemicals through maternal smoking, alcohol use, drug abuse, prescription medicines and occupational/lifestyle exposures is wides…
The primary purpose of this study is to assess the safety of long-acting injectable cabotegravir (CAB-LA) and oral pre-expose prophylaxis (PrEP) (FTC/TDF or 3TC…
The purpose of the study is to evaluate fetal, maternal, and infant outcomes through 12 months of age.
The participants of this study will be of any age who are exposed to at least 1 dose of odevixibat at any time during pregnancy (from 1 day prior to conception…
The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their inf…
This is a Phase 4 observational study designed to assess the impact of Palynziq ® (pegvaliase) treatment in pregnant women with PKU and on their offspring who w…
The study will include participants who were exposed to at least one dose of elafibranor either within the three weeks before conception or at any time during p…
Prenatal exposure to tobacco smoke, whether from active maternal smoking or secondhand exposure, has been associated with adverse neonatal adaptation, metabolic…
This is an observational study in which data from women with Chagas disease who will take or have already taken nifurtimox during pregnancy and the impact on th…